Company intelligence / Profile preview

Defy Therapeutics

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Defy Therapeutics provides Air Fluidized Therapy beds, a gold standard device-based therapy for patients with severe chronic pressure injuries. The company focuses on enabling access to these devices in home and clinical settings and manages insurance approval processes. No drug or biologic clinical trials are reported; the company operates as a commercial medical device provider.

Therapeutic areas: Dermatology
Modalities: Device (Air Fluidized Therapy bed)
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Defy Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Defy Therapeutics.

Explore the full profile